K-RAS-mutated cancer cells secrete tumor-derived granulocyte-macrophage colony-stimulating factor (GM-CSF), promoting the recruitment and expansion of MDSCs in the microenvironment, which are able to suppress the antitumor activity of CD8 cytotoxic T cells [81]. The gene discussed is KRAS; the disease is neoplasm.